Akinori Miyashita

Dr. Akinori Miyashita

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
YZYingyue Zhou
Yingyue Zhou
WSWilbur M. Song
Wilbur M. Song
PAPrabhakar S. Andhey
Prabhakar S. Andhey
ASAmanda Swain
Amanda Swain
TLTyler Levy
Tyler Levy
MCMarco Colonna
Marco Colonna

31 January 2017 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
NHNorikazu Hara
Norikazu Hara
MKMasataka Kikuchi
Masataka Kikuchi
AMAkinori Miyashita
Akinori Miyashita
HHHiroyuki Hatsuta
Hiroyuki Hatsuta
YSYuko Saito
Yuko Saito
RKRyozo Kuwano
Ryozo Kuwano
MicroRNAs (miRNAs) are attractive molecules to utilize as one of the blood-based biomarkers for neurodegenerative disorders such as Alzheimer’s disease (AD) because miRNAs are relatively stable in biofluid, including serum or plasma. To determine blood miRNA biomarkers for AD with next-generation sequencing genome-wide, we first surveyed 45 serum samples. These came from 27 AD patients and 18 controls (discovery set) that underwent autopsy within two weeks after their serum sampling and were neuropathologically diagnosed. We found that three miRNAs, hsa-miR-501-3p, hsa-let-7f-5p, and hsa-miR-26b-5p, were significantly deregulated between the AD samples and the controls. The deregulation for hsa-miR-501-3p was further confirmed by quantitative reverse transcription polymerase chain reaction (PCR) in a validation set composed of 36 clinically diagnosed AD patients and 22 age-matched cognitively normal controls with a sensitivity and specificity of 53% and 100%, respectively (area under the curve = 0.82). Serum hsa-miR-501-3p levels were downregulated in AD patients, and its lower levels significantly correlated with lower Mini-Mental State Examination scores. Contrary to its serum levels, we found that hsa-miR-501-3p was remarkably upregulated in the same donors’ AD brains obtained at autopsy from the discovery set. The hsa-miR-501-3p overexpression in cultured cells, which mimicked the hsa-miR-501-3p upregulation in the AD brains, induced significant downregulation of 128 genes that overrepresented the Gene Ontology terms, DNA replication, and the mitotic cell cycle. Our results suggest that hsa-miR-501-3p is a novel serum biomarker that presumably corresponds to pathological events occurring in AD brains.

30 May 2012 in BMC Systems Biology
Verified
Journal Article
Open access
PDF file
SMSatoshi Mizuno
Satoshi Mizuno
RIRisa Iijima
Risa Iijima
SOSoichi Ogishima
Soichi Ogishima
MKMasataka Kikuchi
Masataka Kikuchi
YMYukiko Matsuoka
Yukiko Matsuoka
HTHiroshi Tanaka
Hiroshi Tanaka
Background: Alzheimer’s disease (AD) is the most common cause of dementia among the elderly. To clarify pathogenesis of AD, thousands of reports have been accumulating. However, knowledge of signaling pathways in the field of AD has not been compiled as a database before.Description: Here, we have constructed a publicly available pathway map called “AlzPathway” that comprehensively catalogs signaling pathways in the field of AD. We have collected and manually curated over 100 review articles related to AD, and have built an AD pathway map using CellDesigner. AlzPathway is currently composed of 1347 molecules and 1070 reactions in neuron, brain blood barrier, presynaptic, postsynaptic, astrocyte, and microglial cells and their cellular localizations. AlzPathway is available as both the SBML (Systems Biology Markup Language) map for CellDesigner and the high resolution image map. AlzPathway is also available as a web service (online map) based on Payao system, a community-based, collaborative web service platform for pathway model curation, enabling continuous updates by AD researchers.Conclusions: AlzPathway is the first comprehensive map of intra, inter and extra cellular AD signaling pathways which can enable mechanistic deciphering of AD pathogenesis. The AlzPathway map is accessible athttp://alzpathway.org/.

3 March 2021 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
DSDaichi Shigemizu
Daichi Shigemizu
RMRisa Mitsumori
Risa Mitsumori
SAShintaro Akiyama
Shintaro Akiyama
AMAkinori Miyashita
Akinori Miyashita
TMTakashi Morizono
Takashi Morizono
KOKouichi Ozaki
Kouichi Ozaki
Alzheimer’s disease (AD) has no cure, but early detection and risk prediction could allow earlier intervention. Genetic risk factors may differ between ethnic populations. To discover novel susceptibility loci of AD in the Japanese population, we conducted a genome-wide association study (GWAS) with 3962 AD cases and 4074 controls. Out of 4,852,957 genetic markers that passed stringent quality control filters, 134 in nine loci, includingAPOEandSORL1, were convincingly associated with AD. Lead SNPs located in seven novel loci were genotyped in an independent Japanese AD case–control cohort. The novel locusFAM47Ereached genome-wide significance in a meta-analysis of association results. This is the first report associating theFAM47Elocus with AD in the Japanese population. A trans-ethnic meta-analysis combining the results of the Japanese data sets with summary statistics from stage 1 data of the International Genomics of Alzheimer’s Project identified an additional novel susceptibility locus inOR2B2. Our data highlight the importance of performing GWAS in non-European populations.

1 August 2018 in Brain Research
Verified
Journal Article
Open access
PGPeter St George-Hyslop
Peter St George-Hyslop
JLJulie Qiaojin Lin
Julie Qiaojin Lin
AMAkinori Miyashita
Akinori Miyashita
EPEmma C. Phillips
Emma C. Phillips
SQSeema Qamar
Seema Qamar
GWGuoZhen Wang
GuoZhen Wang
Many RNA binding proteins, including FUS, contain moderately repetitive, low complexity, intrinsically disordered domains. These sequence motifs have recently been found to underpin reversible liquid: liquid phase separation and gelation of these proteins, permitting them to reversibly transition from a monodispersed state to liquid droplet- or hydrogel-like states. This function allows the proteins to serve as scaffolds for the formation of reversible membraneless intracellular organelles such as nucleoli, stress granules and neuronal transport granules. Using FUS as an example, this review examines the biophysics of this physiological process, and reports on how mutations and changes in post-translational state alter phase behaviour, and lead to neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

24 February 2005 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
AIAtsushi Ishikawa
Atsushi Ishikawa
YPYue‐Shan Piao
Yue‐Shan Piao
AMAkinori Miyashita
Akinori Miyashita
RKRyozo Kuwano
Ryozo Kuwano
OOOsamu Onodera
Osamu Onodera
HTHitoshi Takahashi
Hitoshi Takahashi